An Official Website of the United States Government
Search
Narrow Search Filters:
Year:2010
Company: DAYSTAR RESEARCH Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): This Phase 1 STTR application seeks support for research to enhance the commercial viability of a tool to assess the cultural competence of health care organizations. The tool was developed by Dr. Thomas A. LaVeist,who is director of the Hopkins Center for… more
Company: INDEPENDENT SCHOLAR--AVRIN, WILLIAM F. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): This STTR program will test the utility of a low-cost device for noninvasive liver iron measurements, by using the device to determine the prevalence of iron overload in African Americans. African American iron overloadis both an under-studied health issue in a… more
Company: ELECTRONIC MEDICAL OFFICE LOGISTICS, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Over 1,437,180 patients were diagnosed with cancer in 2008; over half were solid tumors. Cancer patients experience a number of life-altering symptoms during chemotherapy. Treatments have become more aggressive, are administered in outpatient settings, and in… more
Company: PATIENT PROVIDER COMMUNICATIONS, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Patient Provider Communications will develop EloquenceTM based on data acquired from research conducted by the University of Michigan School of Nursing addressing the specific aims and hypothesis. This project extends the research team's preliminary findings… more
Company: CDI LABORATORIES, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Antigen-microarray validated monoclonal antibody library for analysis of brain- expressed proteins implicated in human mental disorders. Summary This is a proposal to produce a targeted set of monoclonal antibodies to be commercialized in a variety of ways (see… more
Company: FLOCEL INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Increasing evidence indicates that systemic inflammation and the blood-brain barrier (BBB), which becomes the target of overreacting or misguided immune cells that determine BBB failure and immune extravasations into the brain parenchyma, are involved in the… more
Company: POPULATION DIAGNOSTICS, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): The goal of this project is to rapidly discover biomarkers for Parkinson's Disease (PD) by defining the spectrum of causal genetic loci for PD, not only for the purpose of accurate diagnosis and risk stratification butalso in order to shed light on the… more
Company: REGENERATION MATRIX, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Regeneration Matrix's technology, licensed from Georgia Tech, enables the design of a next generation nerve guide product to bridge large peripheral nerve gaps created due to trauma, tumor resection, or reconstructive surgery. The fundamental technology… more
Company: HYBERNIA MEDICAL, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Hypothermia is a powerful neuroprotective treatment for ischemic injury and is indicated for use in cardiopulmonary bypass, cardiac arrest, and neonatal hypoxia. However, current methods induce systemic hypothermia which requires significant time and has… more
Company: INTEGRATED TISSUE DYNAMICS, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Wide varieties of peripheral neuropathies accompanied by severe chronic pain are among the most common and debilitating human afflictions. Existing treatments have little long term benefits and often have severe side effects. Increasing evidence indicates that… more
Company: CORE 12, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): An absence of age-appropriate assessment technologies has hindered the ability of health, mental health, and school psychology professional to obtain and utilize self- report information from young children. This gap isproblematic for science and applied fields… more
Company: STONY BROOK BIOTECHNOLOGY Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Our goal is to develop an In Vitro Diagnostic Multivariate Assay (IVDMIA) to distinguish Essential Thrombocythemia (ET) from non-clonal reactive thrombocytosis (RT) etiologies. ET represents a distinct subtype of myeloproliferative disorders, thrombocytosis,… more
Company: SGM BIOTECH, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): This STTR application is to develop and test for eventual clinical use a new strategy for tumor specific anticancer drug delivery. The technology, Clostridia-directed enzyme prodrug therapy, or CDEPT, exploits the factthat certain non-pathogenic bacteria of the… more
Company: PRESAGE BIOSCIENCES, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity and other challenges related to treatment. For over 50 years, physicians have used patient-specific… more
Company: ALCOMED, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR project proposes to apply drug delivery technologies to develop a novel use for a nasally delivered… more
Company: MUVE, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): It is uniformly recognized that sedentariness - the sitting disease - is bad for the health of the nation. The solution to reversing sedentariness involves devising and disseminating real-world solutions to promote day-long physical activity and help people who… more
Company: VIRTUAL PHANTOMS, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): This project aims to develop a commercial software product, VirtualDoseTM, for calculating and analyzing patient radiation doses from x-ray computed tomography (CT) examinations. Despite its essential role in radiology, CT is responsible for raising the… more
Company: MICRO VIDE, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): A major cause of morbidity and mortality in cardiovascular surgery is excessive bleeding post- operatively, which is commonly managed by pharmacologically modifying clot degradation (fibrinolysis), through inhibition of plasmin activity (PLact). However,… more
Company: ENGINEERING ARTS, LLC Agency/Program/Year/Phase: HHS / STTR / 2010 / 1
Abstract: DESCRIPTION (provided by applicant): Among the currently available techniques for high throughput proteomics, protein microarrays have the greatest prospects to revolutionize molecular diagnostics for early detection, diagnosis, treatment, prognosis and monitoring clinical response. However, protein… more
Company: VESTAN, INC. Agency/Program/Year/Phase: HHS / STTR / 2010 / 2
Abstract: DESCRIPTION (provided by applicant): In this Phase II STTR project, Vestan Medical Imaging, Inc. will complete the development and clinical evaluation of its proprietary formulation of a fluorescent drug and new medical devices for Sentinel Lymph Node (SLN) biopsy for the surgical treatment of… more
Company: MITOSCIENCES, INC Agency/Program/Year/Phase: HHS / STTR / 2010 / 2
Abstract: DESCRIPTION (provided by applicant): Highly Active Anti-Retroviral Therapy (HAART) used to treat HIV/AIDS has serious side-effects, including metabolic complications from mitochondrial toxicities that can be life-threatening, and limit effectiveness and patient compliance. Adverse metabolic effects… more
Company: L-NUTRA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2010 / 1
Abstract: The contractor proposes to: 1) develop gel-based formulations that allow the feeding of mice with a variety of altered diets, 2) determine the level of caloric restriction necessary for protection against chemotherapy and identify dietary components whose deficiency is sufficient to provide a… more
Company: FORRESTER CONSTRUCTION COMPANY Agency/Program/Year/Phase: HHS / SBIR / 2010 / 1
Abstract: Not Available
HELP FOR NARROW YOUR SEARCH
Search Options
Search for Either Criteria
Narrowing the Search Results
Search Options
There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.
Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.
Search for Either Criteria
When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.
Narrowing the Search Results
You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.